IHAM
GOSS icon

Integral Health Asset Management’s Gossamer Bio GOSS Stock Holding History

Integral Health Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100,000
Closed -$1.24M – 70
2020
Q3 		$1.24M Buy
+100,000
New +$1.33M 0.38% 65

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Integral Health Asset Management's GOSS Position: Q1 2026 in Review

Integral Health Asset Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 1,000,000 shares — an estimated $3.1M sold.

Integral Health Asset Management first reported a position in GOSS in Q4 2019 and held it in 5 quarters. The position peaked at $3.59M in Q3 2022. 185 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Integral Health Asset Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Integral Health Asset Management sold 1,000,000 Gossamer Bio shares in Q1 2026, an estimated $3.1M.
  • Integral Health Asset Management first reported a position in Gossamer Bio in Q4 2019 and held it in 5 quarters.
  • Integral Health Asset Management's Gossamer Bio position peaked at $3.59M in Q3 2022.
  • 185 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.